Rekambys

rilpivirine · Janssen-Cilag International NV

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rekambys, covering 2025-11-04 to 2025-11-04. Get the full timeline:

Most recent: EMA Authorised: Rekambys (rilpivirine) — Janssen-Cilag International NV